류마티스 관절염 진단 기기 시장(2026-2030년)

The global rheumatoid arthritis diagnostic devices market is forecasted to grow by USD 131.2 mn during 2025-2030, accelerating at a CAGR of 4.7% during the forecast period. The report on the global rheumatoid arthritis diagnostic devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global prevalence of autoimmune disorders, technological innovations in microarray biomarker assays, increasing demand for early clinical intervention.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global rheumatoid arthritis diagnostic devices market is segmented as below:

By Product

• Analyzers
• Consumables

By End-User

• Hospitals and specialty clinics
• Diagnostic laboratories
• Ambulatory surgical centers (ASCs)
• Research institutes

By Test

• Serology tests
• Disease monitoring tests

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the artificial intelligence integration in diagnostic imaging as one of the prime reasons driving the global rheumatoid arthritis diagnostic devices market growth during the next few years. Also, rising clinical reliance on companion diagnostics and expansion of automated serological analyzer systems will lead to sizable demand in the market.

The report on the global rheumatoid arthritis diagnostic devices market covers the following areas:

• Global rheumatoid arthritis diagnostic devices market sizing
• Global rheumatoid arthritis diagnostic devices market forecast
• Global rheumatoid arthritis diagnostic devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global rheumatoid arthritis diagnostic devices market vendors that include A. Menarini Diagnostics S.r.l., Abbott Laboratories, Autobio Diagnostics Co. Ltd., Bio Rad Laboratories Inc., Corgen Bio, DiaSorin SpA, Esaote SpA, EUROIMMUN, F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., Genrui Biotech Inc., Guangzhou Wondfo Biotech Co. Ltd., J. Mitra and Co. Pvt. Ltd., Maccura Biotechnology Co. Ltd., QuidelOrtho Corp., SEBIA SA, Shenzhen Mindray Co. Ltd., Siemens Healthineers AG, Snibe Co.Ltd., Svar Life Science AB, Thermo Fisher Scientific Inc., Werfenlife SA, Zybio Inc.. Also, the global rheumatoid arthritis diagnostic devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Test
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Rheumatoid Arthritis Diagnostic Devices Market 2020 - 2024
  • Historic Market Size - Data Table on Global Rheumatoid Arthritis Diagnostic Devices Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Test segment analysis 2020 - 2024
  • Historic Market Size - Test Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Rheumatoid Arthritis Diagnostic Devices Market
• 6.2 Impact of geopolitical conflicts on Global Rheumatoid Arthritis Diagnostic Devices Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Analyzers - Market size and forecast 2025-2030
• 8.4 Consumables - Market size and forecast 2025-2030
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospitals and specialty clinics - Market size and forecast 2025-2030
• 9.4 Diagnostic laboratories - Market size and forecast 2025-2030
• 9.5 Ambulatory surgical centers (ASCs) - Market size and forecast 2025-2030
• 9.6 Research institutes - Market size and forecast 2025-2030
• 9.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Test

• 10.1 Market segments
• 10.2 Comparison by Test
• 10.3 Serology tests - Market size and forecast 2025-2030
• 10.4 Disease monitoring tests - Market size and forecast 2025-2030
• 10.5 Market opportunity by Test
  • Market opportunity by Test ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Thailand - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Argentina - Market size and forecast 2025-2030
  • 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.4 Colombia - Market size and forecast 2025-2030
  • 12.6.5 UAE - Market size and forecast 2025-2030
  • 12.6.6 South Africa - Market size and forecast 2025-2030
  • 12.6.7 Israel - Market size and forecast 2025-2030
  • 12.6.8 Turkey - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising global prevalence of autoimmune disorders
  • Technological innovations in microarray biomarker assays
  • Increasing demand for early clinical intervention
• 13.2 Market challenges
  • Persistent ambiguity in seronegative rheumatoid diagnostics
  • High capital expenses in advanced diagnostic infrastructure
  • Reimbursement disparities across diverse global healthcare systems
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Artificial intelligence integration in diagnostic imaging
  • Rising clinical reliance on companion diagnostics
  • Expansion of automated serological analyzer systems

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 A. Menarini Diagnostics S.r.l.
  • A. Menarini Diagnostics S.r.l. - Overview
  • A. Menarini Diagnostics S.r.l. - Product / Service
  • A. Menarini Diagnostics S.r.l. - Key offerings
  • SWOT
• 15.5 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.6 Autobio Diagnostics Co. Ltd.
  • Autobio Diagnostics Co. Ltd. - Overview
  • Autobio Diagnostics Co. Ltd. - Product / Service
  • Autobio Diagnostics Co. Ltd. - Key offerings
  • SWOT
• 15.7 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.8 DiaSorin SpA
  • DiaSorin SpA - Overview
  • DiaSorin SpA - Business segments
  • DiaSorin SpA - Key news
  • DiaSorin SpA - Key offerings
  • DiaSorin SpA - Segment focus
  • SWOT
• 15.9 EUROIMMUN
  • EUROIMMUN - Overview
  • EUROIMMUN - Product / Service
  • EUROIMMUN - Key offerings
  • SWOT
• 15.10 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.11 Fujirebio Holdings Inc.
  • Fujirebio Holdings Inc. - Overview
  • Fujirebio Holdings Inc. - Product / Service
  • Fujirebio Holdings Inc. - Key offerings
  • SWOT
• 15.12 Guangzhou Wondfo Biotech Co. Ltd.
  • Guangzhou Wondfo Biotech Co. Ltd. - Overview
  • Guangzhou Wondfo Biotech Co. Ltd. - Product / Service
  • Guangzhou Wondfo Biotech Co. Ltd. - Key offerings
  • SWOT
• 15.13 Maccura Biotechnology Co. Ltd.
  • Maccura Biotechnology Co. Ltd. - Overview
  • Maccura Biotechnology Co. Ltd. - Product / Service
  • Maccura Biotechnology Co. Ltd. - Key offerings
  • SWOT
• 15.14 QuidelOrtho Corp.
  • QuidelOrtho Corp. - Overview
  • QuidelOrtho Corp. - Business segments
  • QuidelOrtho Corp. - Key offerings
  • QuidelOrtho Corp. - Segment focus
  • SWOT
• 15.15 Shenzhen Mindray Co. Ltd.
  • Shenzhen Mindray Co. Ltd. - Overview
  • Shenzhen Mindray Co. Ltd. - Business segments
  • Shenzhen Mindray Co. Ltd. - Key offerings
  • Shenzhen Mindray Co. Ltd. - Segment focus
  • SWOT
• 15.16 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 15.17 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
• 15.18 Werfenlife SA
  • Werfenlife SA - Overview
  • Werfenlife SA - Product / Service
  • Werfenlife SA - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations